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When to Suspect EEE 
EEE in Massachusetts Residents by Year, 1938-2012    
Years not shown had no reported cases 
Year(s) Number of Confirmed 
Human Cases 
Number of 
Deaths 
1938-39 35 25 
1955-1965 16 9 
1970 1 0 
1973-75 6* 4 
1982-84 10** 3 
1990 3 1 
1992 1 0 
1995 1 1 
1997 1 0 
2000 1 0 
2001 1 0 
2004 4 2 
2005 4 2 
2006 5 2 
2008 1 1 
2010 2*** 0 
2011 2*** 1 
2012 7 3 
Total 99 54 
* One case in 1973 consistent with exposure in NH                                      
** One case in 1984 consistent with exposure in NJ                                     
*** One case in 2010 and one in 2011 occurred in out-of-state residents 
Background 
EEE is caused by the most neuropathogenic 
arbovirus transmitted in the United States.  EEE is 
relatively rare, since the EEE virus was first 
identified in Massachusetts in 1938, 99 cases have 
occurred with exposure in the state. However, the 
mortality rate for those affected is high, and 
survivors often suffer severe neurological sequelae.  
 
The virus is maintained in nature in a bird-mosquito 
cycle that occasionally spills over into mammals, 
including humans.  Humans are considered 
incidental hosts and do not perpetuate the cycle. 
 
Since 2000, most cases have occurred in Bristol and 
Plymouth counties. However, during 2012, spillover 
of EEE to humans and animals also occurred in 
Essex, Middlesex, Worcester, Franklin and 
Hampshire counties. The greatest risk for EEE 
occurs from late July through September.  People 
under 15 years of age or over 50 years of age are at 
greatest risk for serious illness. 
Central nervous system infection with EEE virus most commonly presents as encephalitis.  The symptoms 
may present acutely or sub-acutely, but typically include fever, headache, alterations in level of 
consciousness, lethargy, confusion and seizures.  Since encephalitis can coexist with inflammation of the 
meninges, symptoms of meningitis, such as headache and stiff neck, may predominate.  Suspect cases of 
encephalitis or meningitis, regardless of etiology, should be reported as soon as possible to the local 
board of health and the MDPH, Division of Epidemiology and Immunization, at 1-617-983-6800 or 1-
888-658-2850. 
 
Prevention Messages for Your Patients 
• Use an EPA approved mosquito repellent according to the instructions on the product label.  Review the 
MDPH Fact Sheet on Mosquito Repellents online at www.mass.gov/dph/mosquito. Additional 
information, including repellent selector tools, is available at http://cfpub.epa.gov/oppref/insect/ and 
http://pi.ace.orst.edu/repellents/. 
• Wear long pants, a long-sleeved shirt and socks to reduce exposed skin outdoors, weather permitting. 
• Keep mosquitoes out of the house by repairing any holes in screens and making sure they are 
tightly attached to all doors and windows. 
• When elevated EEE risk exists in an area, people in that area should be encouraged to avoid outdoor 
events between dusk and dawn when mosquitoes most likely to carry EEE are most active. 
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Hinton State Laboratory Institute 
Diagnostic Testing for Arboviruses in Humans 
 
How to Test for EEE 
In order to confirm suspect cases of EEE, it is vital that you send the appropriate samples to the MDPH 
Hinton State Laboratory Institute (HSLI) for testing. 
 
Serologic tests and viral culture are available for diagnostic testing for evidence of infection with West 
Nile virus (WNV), eastern equine encephalitis (EEE) virus and other arboviruses.  PCR is also 
available for detection of RNA of WNV and EEE virus.  Multiple tests will be performed to identify 
viral infection and/or confirm exposure to virus.  Testing may require that follow up (convalescent) 
specimens be submitted.  
  
The following information is critical for accurate interpretation of test results: 
• Date of onset of disease symptoms 
• Date of specimen collection 
• Unusual immunological status of patient (e.g. immunosuppression) 
• Travel history (e.g., travel to flavivirus-endemic areas) 
• Vaccination history (e.g., vaccination against yellow fever, Japanese encephalitis or Central European 
encephalitis) 
• Disease history (e.g., previous history of viral encephalitis or dengue fever) 
• Brief clinical summary including suspected diagnosis (e.g., encephalitis or meningitis) 
 
Specimen types and amounts 
Acute serum (≥ 3ml) and CSF (≥ 1ml) should be collected within the first 14 days following onset of 
symptoms and sent immediately to the HSLI.  IgM antibody in serum is present in the majority of infected 
individuals by day 8, but may be present earlier.  By 3 weeks after onset (often earlier), virtually all infected 
individuals will have IgG antibody by enzyme immunoassay (EIA) and plaque reduction neutralization assay 
(PRNT).  In general, convalescent specimens should be drawn approximately 10-14 days after acute phase 
specimens. 
 
CSF, brain and other tissues will be evaluated by cell culture and, if a sufficient specimen is available, 
by PCR.  Specimens submitted for viral isolation within 48 hrs should be stored and shipped at 4°C.  If 
already frozen, specimens should be shipped on dry ice. 
 
Clinical specimens should be submitted using the State Laboratory Institute’s clinical specimen submission form 
(SS-SL-1-05) (http://www.mass.gov/eohhs/docs/dph/laboratory-sciences/general-submission-form.pdf).  
Additional arboviral information can be found on MDPH’s arbovirus website: 
(http://www.mass.gov/dph/mosquito). 
Hinton State Laboratory Institute 
Bureau of Laboratory Sciences 
Division of Molecular Diagnostics and Virology 
305 South Street 
Boston, MA 02130 
Virology Laboratories: (617) 983-6396 or 6382 
 
 
MDPH Arbovirus Website 
Page 3 of 2            June 2013 
 
www.mass.gov/dph/mosquito 
